Similar articles for PMID: 24595494

Year	Number of Results
2007	2
2008	1
2009	1
2010	7
2011	14
2012	7
2013	9
2014	15
2015	10
2016	9
2017	9
2018	9
2019	13
2020	5
2021	13
2022	13
2023	5
2024	0

1

Theranostic nanoparticles for cancer and cardiovascular applications.

Wang D, Lin B, Ai H. Wang D, et al. Pharm Res. 2014 Jun;31(6):1390-406. doi: 10.1007/s11095-013-1277-z. Epub 2014 Mar 5. Pharm Res. 2014. PMID: 24595494 Review.

2

Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.

Sharma R, Mody N, Agrawal U, Vyas SP. Sharma R, et al. Mini Rev Med Chem. 2017;17(18):1746-1757. doi: 10.2174/1389557516666160219122524. Mini Rev Med Chem. 2017. PMID: 26891932 Review.

3

All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.

Cai Y, Chen X, Si J, Mou X, Dong X. Cai Y, et al. Small. 2021 Dec;17(52):e2103072. doi: 10.1002/smll.202103072. Epub 2021 Sep 24. Small. 2021. PMID: 34561968 Review.

4

Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.

Godin B, Sakamoto JH, Serda RE, Grattoni A, Bouamrani A, Ferrari M. Godin B, et al. Trends Pharmacol Sci. 2010 May;31(5):199-205. doi: 10.1016/j.tips.2010.01.003. Epub 2010 Feb 19. Trends Pharmacol Sci. 2010. PMID: 20172613 Free PMC article. Review.

5

Copper sulfide: An emerging adaptable nanoplatform in cancer theranostics.

Poudel K, Gautam M, Jin SG, Choi HG, Yong CS, Kim JO. Poudel K, et al. Int J Pharm. 2019 May 1;562:135-150. doi: 10.1016/j.ijpharm.2019.03.043. Epub 2019 Mar 20. Int J Pharm. 2019. PMID: 30904728 Review.

6

Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles.

Cabral RM, Baptista PV. Cabral RM, et al. Expert Rev Mol Diagn. 2014 Nov;14(8):1041-52. doi: 10.1586/14737159.2014.965683. Epub 2014 Oct 15. Expert Rev Mol Diagn. 2014. PMID: 25314939 Review.

7

Multifunctional agents for concurrent imaging and therapy in cardiovascular disease.

McCarthy JR. McCarthy JR. Adv Drug Deliv Rev. 2010 Aug 30;62(11):1023-30. doi: 10.1016/j.addr.2010.07.004. Epub 2010 Jul 21. Adv Drug Deliv Rev. 2010. PMID: 20654664 Free PMC article. Review.

8

Theranostic applications of nanoparticles in cancer.

Ahmed N, Fessi H, Elaissari A. Ahmed N, et al. Drug Discov Today. 2012 Sep;17(17-18):928-34. doi: 10.1016/j.drudis.2012.03.010. Epub 2012 Mar 30. Drug Discov Today. 2012. PMID: 22484464 Review.

9

Nanoparticle-based theranostic agents.

Xie J, Lee S, Chen X. Xie J, et al. Adv Drug Deliv Rev. 2010 Aug 30;62(11):1064-79. doi: 10.1016/j.addr.2010.07.009. Epub 2010 Aug 4. Adv Drug Deliv Rev. 2010. PMID: 20691229 Free PMC article. Review.

10

Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.

Caldorera-Moore ME, Liechty WB, Peppas NA. Caldorera-Moore ME, et al. Acc Chem Res. 2011 Oct 18;44(10):1061-70. doi: 10.1021/ar2001777. Epub 2011 Sep 20. Acc Chem Res. 2011. PMID: 21932809 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

128 results

Results by year